Irit Arbel

Executive

US·SEC (Form 4)

Brainstorm Cell Therapeutics Inc.

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

—

Latest filing published 29 May 2026 for Brainstorm Cell Therapeutics INC.. Read the official filing

Insider track record

Disclosed buys

Disclosed sells

Signal history

No signal scores available.

Irit Arbel: trading record in brief

Irit Arbel appears in our data through filings on Brainstorm Cell Therapeutics Inc. shares, published by SEC (Form 4). The record holds 2 filings, for trades running from 1 January 2025 to 26 February 2026.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

The newest entry dates from 29 May 2026: a share grant, in Brainstorm Cell Therapeutics Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.